Lymphatica vince l’Italian Patent Competition,  250.000 euro al progetto che dà speranza ai pazienti con linfedema

Premiato il progetto di sviluppo di un dispositivo impiantabile per il trattamento del linfedema cronico. Menzione speciale per Ananas Liver (nanoparticelle per la cura di malattie del fegato) e ChemiCare (nuovi composti per il trattamento di malattie rare)

Add Widget Column

Manage Cookie Consent

To ensure the best possible browsing experience, this site uses technical, statistical and anonymous third-party cookies. to know more

Functional

Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Preferences

{title} {title} {title}

Lymphatica vince l’Italian Patent Competition, 250.000 euro al progetto che dà speranza ai pazienti con linfedema

Lymphatica vince l’Italian Patent Competition,  250.000 euro al progetto che dà speranza ai pazienti con linfedema